Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms

Successful cancer management depends on accurate diagnostics along with specific treatment protocols. Current diagnostic techniques need to be improved to provide earlier detection capabilities, and traditional chemotherapy approaches to cancer treatment are limited by lack of specificity and systemic toxicity. This review highlights advances in nanotechnology that have allowed the development of multifunctional platforms for cancer detection, therapy, and monitoring. Nanomaterials can be used as MRI, optical imaging, and photoacoustic imaging contrast agents. When used as drug carriers, nanoformulations can increase tumor exposure to therapeutic agents and result in improved treatment effects by prolonging circulation times, protecting entrapped drugs from degradation, and enhancing tumor uptake through the enhanced permeability and retention effect as well as receptor-mediated endocytosis. Multiple therapeutic agents such as chemotherapy, antiangiogenic, or gene therapy agents can be simultaneously delivered by nanocarriers to tumor sites to enhance the effectiveness of therapy. Additionally, imaging and therapy agents can be co-delivered to provide seamless integration of diagnostics, therapy, and follow-up, and different therapeutic modalities such as chemotherapy and hyperthermia can be co-administered to take advantage of synergistic effects. Liposomes, metallic nanoparticles, polymeric nanoparticles, dendrimers, carbon nanotubes, and quantum dots are examples of nanoformulations that can be used as multifunctional platforms for cancer theranostics. Nanomedicine approaches in cancer have great potential for clinically translatable advances that can positively impact the overall diagnostic and therapeutic process and result in enhanced quality of life for cancer patients. However, a concerted scientific effort is still necessary to fully explore long-term risks, effects, and precautions for safe human use.

[1]  G. Storm,et al.  Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.

[2]  Thommey P. Thomas,et al.  Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.

[3]  Xiang Li,et al.  Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. , 2010, International journal of pharmaceutics.

[4]  Y. S. Tarahovsky “Smart” liposomal nanocontainers in biology and medicine , 2010, Biochemistry (Moscow).

[5]  F. Dosio,et al.  From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy , 2003, Tumori.

[6]  H. Kantarjian,et al.  Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Basu,et al.  Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation , 2010, International journal of nanomedicine.

[8]  K. Leong,et al.  Chitosan‐g‐PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions , 2006, The journal of gene medicine.

[9]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[10]  A. Fernandez-Fernandez,et al.  Simultaneous Delivery of Chemotherapeutic and Thermal-Optical Agents to Cancer Cells by a Polymeric (PLGA) Nanocarrier: An In Vitro Study , 2010, Pharmaceutical Research.

[11]  T. Allen The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system , 1994 .

[12]  Ick Chan Kwon,et al.  The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Jennifer L West,et al.  Nanoparticles for thermal cancer therapy. , 2009, Journal of biomechanical engineering.

[14]  M. Paul,et al.  6-Mercaptopurine and Daunorubicin Double Drug Liposomes—Preparation, Drug-Drug Interaction and Characterization , 2005, Journal of liposome research.

[15]  T. Takei,et al.  Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. , 1993, Journal of microencapsulation.

[16]  A Paul Alivisatos,et al.  Room-temperature single-nucleotide polymorphism and multiallele DNA detection using fluorescent nanocrystals and microarrays. , 2003, Analytical chemistry.

[17]  R. Kanwar,et al.  Foundation review : Antiangiogenic therapy using nanotechnological-based delivery system , 2011 .

[18]  G. Gregoriadis,et al.  Enzyme entrapment in liposomes , 1971, FEBS letters.

[19]  L. Mayer,et al.  Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratios. , 2006, Oncology research.

[20]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[21]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[22]  Michael J Sailor,et al.  Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. , 2008, Angewandte Chemie.

[23]  J. Irache,et al.  Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  John M. Walker,et al.  Molecular Biology and Biotechnology , 1988 .

[25]  Katayoun Derakhshandeh,et al.  Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients , 2010, International journal of nanomedicine.

[26]  V. Torchilin,et al.  Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo , 1991, FEBS letters.

[27]  Qiang Zhang,et al.  Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  M. Porter,et al.  Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels. , 2003, Analytical chemistry.

[29]  Aibing Yu,et al.  Inorganic nanoparticles as carriers for efficient cellular delivery , 2006 .

[30]  G. Birrenbach,et al.  Polymerized micelles and their use as adjuvants in immunology. , 1976, Journal of pharmaceutical sciences.

[31]  A. Giatromanolaki,et al.  Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Janko Kos,et al.  Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[33]  I. Bakker-Woudenberg,et al.  Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[34]  Zheng-Rong Lu,et al.  Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. , 2009, Biomaterials.

[35]  Michael J Sailor,et al.  SERS‐Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near‐Infrared Imaging and Photothermal Heating , 2009, Advanced materials.

[36]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[37]  K. Parang,et al.  Development of cytarabine prodrugs and delivery systems for leukemia treatment , 2010, Expert opinion on drug delivery.

[38]  R. Kannan,et al.  Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.

[39]  Qian Yang,et al.  Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. , 2010, Biomaterials.

[40]  C. Yeh,et al.  Multifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivo. , 2010, Chemical communications.

[41]  D. P. O'Neal,et al.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.

[42]  Jiwei Huang,et al.  Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. , 2010, Biomaterials.

[43]  I. Kwon,et al.  Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Xiaohua Huang,et al.  Peptide-conjugated gold nanorods for nuclear targeting. , 2007, Bioconjugate chemistry.

[45]  V. Castranova,et al.  Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? , 2009, Pharmacology & therapeutics.

[46]  R. Sinclair,et al.  Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation. , 2008, Analytical Chemistry.

[47]  A. Maitra,et al.  Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Martin W. Brechbiel,et al.  Dendrimer-based macromolecular MRI contrast agents: characteristics and application. , 2003 .

[49]  A. Fernandez-Fernandez,et al.  Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[50]  F. Caponigro,et al.  Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  A. Spira,et al.  Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[52]  F. Mollinedo,et al.  Lipid nanomedicines for anticancer drug therapy. , 2009, Journal of biomedical nanotechnology.

[53]  Sheela M. Waugh,et al.  2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.

[54]  J. Kreuter Nanoparticles and microparticles for drug and vaccine delivery. , 1996, Journal of anatomy.

[55]  M. Ziepert,et al.  High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  D. Senger,et al.  Matrix‐specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  H. Kourlas,et al.  Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. , 2006, Clinical therapeutics.

[58]  G Toffoli,et al.  Overexpression of folate binding protein in ovarian cancers , 1997, International journal of cancer.

[59]  A. Anagnostopoulos,et al.  The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia , 2005, Leukemia & lymphoma.

[60]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[61]  Jens Ricke,et al.  Magnetic nanoparticles for interstitial thermotherapy – feasibility, tolerance and achieved temperatures , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[62]  S. Bhatia,et al.  Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.

[63]  Ulrik B Nielsen,et al.  Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Han,et al.  Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. , 2010, Bioconjugate chemistry.

[66]  G. Gregoriadis,et al.  Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. , 1972, European journal of biochemistry.

[67]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[68]  W. Mark Saltzman,et al.  Targeted for drug delivery , 2005 .

[69]  Leaf Huang,et al.  Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[70]  P. Opolon,et al.  Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. , 2006, Human gene therapy.

[71]  S. Chae,et al.  Conjugated chitosan as a novel platform for oral delivery of paclitaxel. , 2008, Journal of medicinal chemistry.

[72]  Murali M. Yallapu,et al.  Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. , 2010, Journal of colloid and interface science.

[73]  David J. Waxman,et al.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment , 2008, Molecular Cancer Therapeutics.

[74]  A. Fernandez-Fernandez,et al.  Comparative Study of the Optical and Heat Generation Properties of IR820 and Indocyanine Green , 2012, Molecular imaging.

[75]  P. Baldrick The safety of chitosan as a pharmaceutical excipient. , 2010, Regulatory toxicology and pharmacology : RTP.

[76]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[77]  F. Szoka,et al.  A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas , 2006, Proceedings of the National Academy of Sciences.

[78]  K. Ulbrich,et al.  Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. , 1995, European journal of cancer.

[79]  J. Hong,et al.  A single intratracheal instillation of single-walled carbon nanotubes induced early lung fibrosis and subchronic tissue damage in mice , 2011, Archives of Toxicology.

[80]  E. Wickstrom,et al.  Single-wall carbon nanotubes with adsorbed antibodies detect live breast cancer cells , 2005 .

[81]  L'Hocine Yahia,et al.  Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. , 2003, Biomaterials.

[82]  T. Minko,et al.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. , 2008, Nanomedicine.

[83]  Hong Xu,et al.  Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. , 2010, ACS nano.

[84]  V. Torchilin,et al.  Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody , 2009, Clinical Cancer Research.

[85]  Ick Chan Kwon,et al.  New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy , 2009 .

[86]  G. Devi,et al.  siRNA-based approaches in cancer therapy , 2006, Cancer Gene Therapy.

[87]  M. Stevens,et al.  Engineering nanocomposite materials for cancer therapy. , 2010, Small.

[88]  J. B. Hall,et al.  Characterization of nanoparticles for therapeutics. , 2007, Nanomedicine.

[89]  G. Liu,et al.  Preparation of Fe3O4–chitosan nanoparticles used for hyperthermia , 2010 .

[90]  C. Lehr,et al.  PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.

[91]  M. Torbenson,et al.  Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery , 2006, International journal of nanomedicine.

[92]  Li Yang,et al.  Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma. , 2010, Journal of pharmaceutical sciences.

[93]  S. Remick,et al.  AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[94]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[95]  D. Mishra,et al.  Chitosan nanoparticles: a promising system in novel drug delivery. , 2010, Chemical & pharmaceutical bulletin.

[96]  P Couvreur,et al.  Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. , 2000, Biomaterials.

[97]  Bin Liu,et al.  A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. , 2010, Biomaterials.

[98]  Neil Desai,et al.  Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[99]  Eun-Mi Kim,et al.  Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. , 2009, International journal of pharmaceutics.

[100]  Breimer Future challenges for drug delivery research. , 1998, Advanced drug delivery reviews.

[101]  L. Stanberry,et al.  VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection , 2007, International journal of nanomedicine.

[102]  Hedi Mattoussi,et al.  Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.

[103]  Chen-Zhong Li,et al.  Whole cell based electrical impedance sensing approach for a rapid nanotoxicity assay , 2010, Nanotechnology.

[104]  T. Park,et al.  In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[105]  Christine Robinson,et al.  Preclinical safety testing of biotechnology-derived pharmaceuticals , 2004, Molecular biotechnology.

[106]  Omid C Farokhzad,et al.  Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates , 2007, ChemMedChem.

[107]  Xiaogang Peng,et al.  Luminescent CdSe/CdS core/shell nanocrystals in dendron boxes: superior chemical, photochemical and thermal stability. , 2003, Journal of the American Chemical Society.

[108]  Kyung-Hwa Yoo,et al.  Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. , 2009, ACS nano.

[109]  Jun Li,et al.  Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer* , 2010, The Journal of Biological Chemistry.

[110]  M. Brandl Liposomes as drug carriers: a technological approach. , 2001, Biotechnology annual review.

[111]  Jin Chang,et al.  PLGA/polymeric liposome for targeted drug and gene co-delivery. , 2010, Biomaterials.

[112]  Michael Hawkins,et al.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  N. K. Jain,et al.  Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics , 2009, Journal of microencapsulation.

[114]  Christine Jérôme,et al.  Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[115]  K. Janes,et al.  Chitosan nanoparticles as delivery systems for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[116]  K. Avgoustakis,et al.  Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. , 2004, Current drug delivery.

[117]  T. Leiner,et al.  Cardiac cine MRI: comparison of 1.5 T, non-enhanced 3.0 T and blood pool enhanced 3.0 T imaging. , 2008, European journal of radiology.

[118]  T. Park,et al.  Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. , 2010, Biomaterials.

[119]  P. Couvreur,et al.  Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[120]  Shiladitya Sengupta,et al.  Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.

[121]  Lawrence Mayer,et al.  In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. , 2009, Leukemia research.

[122]  S. Sahoo,et al.  Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[123]  M. Salzberg,et al.  Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer , 2005, Oncology.

[124]  Thommey P. Thomas,et al.  Dendrimer-based tumor cell targeting of fibroblast growth factor-1. , 2010, Bioorganic & medicinal chemistry letters.

[125]  Philip E. Bourne,et al.  CE-MC: a multiple protein structure alignment server , 2004, Nucleic Acids Res..

[126]  H. von Briesen,et al.  Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. , 2005, Biomaterials.

[127]  Amit Jain,et al.  The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. , 2011, Biomaterials.

[128]  Yan Zhang,et al.  Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[129]  Patrick Couvreur,et al.  A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection , 2009, The Journal of Neuroscience.

[130]  H. Ueno,et al.  Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.

[131]  M. Shive,et al.  Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[132]  Douglas A Christensen,et al.  Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. , 2008, Ultrasonics.

[133]  Xiu-fen Lei,et al.  Measurement of DNA mismatch repair activity in live cells. , 2004, Nucleic acids research.

[134]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[135]  Prashant K. Jain,et al.  Plasmonic photothermal therapy (PPTT) using gold nanoparticles , 2008, Lasers in Medical Science.

[136]  J. Shea,et al.  Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. , 2010, Molecular pharmaceutics.

[137]  S. Haam,et al.  Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. , 2007, Angewandte Chemie.

[138]  Federica Chiellini,et al.  Chitosan—A versatile semi-synthetic polymer in biomedical applications , 2011 .

[139]  Changren Zhou,et al.  Polysaccharides-based nanoparticles as drug delivery systems. , 2008, Advanced drug delivery reviews.

[140]  Michael B. Hall,et al.  Dendritic macromolecules: synthesis of starburst dendrimers , 1986 .

[141]  Kwangmeyung Kim,et al.  Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[142]  Pai-Chi Li,et al.  HER-2 Antibody Conjugated Gold Nano Rod for in Vivo Photothermal Therapy , 2008, 2008 8th IEEE Conference on Nanotechnology.

[143]  Zhuo Georgia Chen,et al.  Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[144]  E. Wickstrom,et al.  Single-wall carbon nanotube nanobomb agents for killing breast cancer cells , 2005 .

[145]  Shimon Weiss,et al.  Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. , 2004, Journal of the American Chemical Society.

[146]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[147]  Y. Jeong,et al.  Polymeric nanoparticle composed of fatty acids and poly(ethylene glycol) as a drug carrier. , 2003, International journal of pharmaceutics.

[148]  Ick Chan Kwon,et al.  Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. , 2010, Journal of Controlled Release.

[149]  Helena R. Chang,et al.  Trastuzumab‐based neoadjuvant therapy in patients with HER2‐positive breast cancer , 2010, Cancer.

[150]  Chad A Mirkin,et al.  Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. , 2006, Journal of the American Chemical Society.

[151]  Feng Liu,et al.  Non‐immunostimulatory nonviral vectors , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[152]  Xiangrong Song,et al.  Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[153]  J. Mcvie,et al.  Albumin microspheres for intra-arterial tumour targeting. I: Pharmaceutical aspects , 1985 .

[154]  P. Low,et al.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. , 2005, Analytical biochemistry.

[155]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[156]  Kemin Wang,et al.  A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. , 2009, Journal of biomedical nanotechnology.

[157]  Sun‐mi Lee,et al.  Synergistic Cancer Therapeutic Effects of Locally Delivered Drug and Heat Using Multifunctional Nanoparticles , 2010, Advanced materials.

[158]  S. Dakhil,et al.  Improved regional selectivity of hepatic arterial bcnu with degradable microspheres , 1982, Cancer.

[159]  S. Nair,et al.  Novel chitin and chitosan nanofibers in biomedical applications. , 2010, Biotechnology advances.

[160]  Forrest M Kievit,et al.  PEI–PEG–Chitosan‐Copolymer‐Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection , 2009, Advanced functional materials.

[161]  B. Axelsson Liposomes as carriers for anti-inflammatory agents , 1989 .

[162]  Keon Wook Kang Preliminary Pre-Clinical Results and Overview on PET/MRI/Fluorescent Molecular Imaging , 2010 .

[163]  D. Wei,et al.  Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles. , 2010, Biomaterials.

[164]  J. Soria,et al.  Use of angiogenesis inhibitors in tumour treatment. , 2005, European journal of cancer.

[165]  T. Allen,et al.  Ligand-targeted liposomes for cancer treatment. , 2005, Current drug delivery.

[166]  Kam W Leong,et al.  Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. , 2011, ACS nano.

[167]  Ji-Xin Cheng,et al.  Controlling the cellular uptake of gold nanorods. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[168]  K. Gupta,et al.  Linear polyethylenimine-graft-chitosan copolymers as efficient DNA/siRNA delivery vectors in vitro and in vivo. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[169]  L. Curiel,et al.  Synergistic inhibitory effect of high‐intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma , 2005, BJU international.

[170]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[171]  Xin Liu,et al.  Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[172]  R. Banerjee,et al.  Liposomes: Applications in Medicine , 2001, Journal of biomaterials applications.

[173]  Howard,et al.  Collected studies on immunity , 2009 .

[174]  Chad A Mirkin,et al.  The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange , 2006, Nature Protocols.

[175]  T. Niidome,et al.  A simple set-and-mix assay for screening of protein kinase inhibitors in cell lysates. , 2011, Analytical biochemistry.

[176]  K. Ishii,et al.  Delivery of Na/I Symporter Gene into Skeletal Muscle Using Nanobubbles and Ultrasound: Visualization of Gene Expression by PET , 2010, Journal of Nuclear Medicine.

[177]  G. Keating,et al.  Bevacizumab: in first-line treatment of advanced and/or metastatic renal cell carcinoma. , 2008, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[178]  K. Gelmon,et al.  Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[179]  Jian Zhang,et al.  Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. , 2002, Human gene therapy.

[180]  J. Couzin Nanoparticles Cut Tumors' Supply Lines , 2002, Science.

[181]  M. Kohl,et al.  Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique. , 1998, Physics in medicine and biology.

[182]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[183]  T. Ponchon,et al.  In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat. , 1974, British Journal of Cancer.

[184]  J. Dijkstra,et al.  The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. , 1981, Biochimica et biophysica acta.

[185]  Vishal Saxena,et al.  Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. , 2006, International journal of pharmaceutics.

[186]  I. Kwon,et al.  Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[187]  P. Lund-johansen,et al.  The dye dilution method for measurement of cardiac output. , 1990, European heart journal.

[188]  T. Bettinger,et al.  Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.

[189]  Y. Pei,et al.  Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. , 2010, Biomaterials.

[190]  P. Fong,et al.  PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[191]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[192]  P. Couvreur,et al.  Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. , 2005, International journal of pharmaceutics.

[193]  N. Nelken,et al.  Advances in stent technology and drug-eluting stents. , 2004, The Surgical clinics of North America.

[194]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[195]  Sang‐wook Lee,et al.  Ki‐67 expression as a prognostic factor in diffuse large B‐cell lymphoma patients treated with rituximab plus CHOP , 2010, European journal of haematology.

[196]  J. Luong,et al.  Fluorescence properties of gold nanorods and their application for DNA biosensing. , 2005, Chemical communications.

[197]  J. Duncan,et al.  Noninvasive fluorescence detection of hepatic and renal function. , 1998, Journal of biomedical optics.

[198]  Alicia Fernandez-Fernandez,et al.  Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. , 2010, Colloids and surfaces. B, Biointerfaces.

[199]  B Ruozi,et al.  PLA/PLGA nanoparticles for sustained release of docetaxel. , 2006, International journal of pharmaceutics.

[200]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.